Credit Suisse
Credit Suisse Group operates as a financial services company. The company operates in three segments: Investment Banking, Private Banking, and Asset Management.
The Investment Banking segment supplies investment banking and securities products and services to corporate, institutional, and government clients worldwide.
The Private Banking segment offers investment advice; wealth management solutions, including pension planning, life insurance products, and tax and wealth planning; and inheritance advice, which is tailored to the needs of high-net-worth individuals.
The Asset Management segment supplies products from the investment classes, such as money market, fixed-income, equities, balanced, and alternative investments to meet the needs of institutional, government, and private clients worldwide.
-
Durata Therapeutics Closes Public Offering of Common Stock
-
Durata Therapeutics (DRTX) Prices 7.15M Shares at $7
-
Durata Therapeutics Prices Public Offering of Common Stock
-
Credit Suisse Assumes Durata Therapeutics (DRTX) at Outperform
-
Credit Suisse Starts Durata Therapeutics (DRTX) at Outperform
-
Notable Analyst Rating Changes 08/13: (GOOG) (IP) (CPB) Upgraded; (P) (TC) (KO) Downgraded
-
Durata Therapeutics (DRTX) Closes 8.63M IPO at $9/Share
-
Durata Therapeutics (DRTX) IPO Opens Slightly Higher
-
Durata Therapeutics (DRTX) IPO Prices at $9, Below Expected Range
-
Durata Therapeutics (DRTX) Sees IPO Price of $11 - $13/Share
-
Durata (DRTX) Files $86.25M IPO
